Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
McKesson
Colorcon
McKinsey

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

UTICORT Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Uticort, and what generic alternatives are available?

Uticort is a drug marketed by Parke Davis and is included in four NDAs.

The generic ingredient in UTICORT is betamethasone benzoate. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone benzoate profile page.

Summary for UTICORT
Drug patent expirations by year for UTICORT
Synonyms for UTICORT
(11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione17-benzoate
(11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl benzoate
22298-29-9
877K0XW47A
9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl benzoate, (11.beta.,16.beta.)-#
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-benzoate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-benzoate
Beben
Benisone
Betamethasone 17-benzoate
BETAMETHASONE BENZOATE
Betamethasone benzoate (USP)
Betamethasone benzoate [USAN:BAN]
Betamethasone benzoate [USAN:USP]
betamethasone-17-benzoate
Bethamethasone 17-benzoate
C29H33FO6
CHEBI:135798
CHEMBL1200376
CS-7216
D02286
DTXSID2022670
EINECS 244-897-9
Euvaderm
Flurobate
FT-0696623
HY-U00161
LS-118426
MS 1112
Parbetan
Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-,(11-beta,16-beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-, 17-benzoate
Q27269802
SCHEMBL49469
SOQJPQZCPBDOMF-YCUXZELOSA-N
UNII-877K0XW47A
Uticort (TN)
W 5975
W-5975
ZINC4212134

US Patents and Regulatory Information for UTICORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis UTICORT betamethasone benzoate CREAM;TOPICAL 016998-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis UTICORT betamethasone benzoate OINTMENT;TOPICAL 018089-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis UTICORT betamethasone benzoate GEL;TOPICAL 017244-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis UTICORT betamethasone benzoate LOTION;TOPICAL 017528-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
McKesson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.